Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.52 - $8.0 $146,448 - $259,200
-32,400 Reduced 42.97%
43,000 $194,000
Q2 2024

Aug 15, 2024

SELL
$5.27 - $10.82 $119,628 - $245,614
-22,700 Reduced 23.14%
75,400 $445,000
Q1 2024

May 07, 2024

BUY
$5.59 - $15.71 $392,977 - $1.1 Million
70,300 Added 252.88%
98,100 $1.06 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $36,418 - $183,480
27,800 New
27,800 $183,000
Q1 2023

May 16, 2023

BUY
$3.37 - $6.3 $10,447 - $19,530
3,100 Added 24.8%
15,600 $55,000
Q4 2022

Feb 14, 2023

SELL
$5.14 - $14.35 $863,006 - $2.41 Million
-167,900 Reduced 93.07%
12,500 $74,000
Q3 2022

Nov 14, 2022

SELL
$12.27 - $18.39 $653,991 - $980,187
-53,300 Reduced 22.81%
180,400 $2.37 Million
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $1.43 Million - $3.57 Million
183,400 Added 364.61%
233,700 $2.88 Million
Q1 2022

May 16, 2022

BUY
$8.66 - $14.99 $151,550 - $262,325
17,500 Added 53.35%
50,300 $572,000
Q4 2021

Feb 14, 2022

BUY
$12.79 - $26.88 $314,634 - $661,248
24,600 Added 300.0%
32,800 $503,000
Q3 2021

Nov 15, 2021

SELL
$26.67 - $38.76 $178,689 - $259,692
-6,700 Reduced 44.97%
8,200 $228,000
Q1 2021

May 17, 2021

BUY
$31.33 - $59.61 $466,817 - $888,189
14,900 New
14,900 $490,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $123M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.